Cargando…

Pulmonary Fibrosis and Antioxidants: Finding the Right Target

Detalles Bibliográficos
Autores principales:	Diebold, Lauren P., Jain, Manu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324037/ https://www.ncbi.nlm.nih.gov/pubmed/37037026 http://dx.doi.org/10.1165/rcmb.2023-0110ED

Ejemplares similares

Aortic Aneurysm: Finding the Right Target
por: Kaschina, Elena
Publicado: (2023)

Combination Therapy with Lumacaftor–Ivacaftor in Cystic Fibrosis. Keeping It Real
por: Sala, Marc A., et al.
Publicado: (2020)

Idiopathic Pulmonary Fibrosis and Lung Cancer: Finding Similarities within Differences
por: Reyfman, Paul A., et al.
Publicado: (2019)

Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Finding the Right Biological: Eosinophil Subset Differences in Asthma and Chronic Obstructive Pulmonary Disease
por: Freeman, Christine M., et al.
Publicado: (2023)

Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis
por: Aliannejad, Rasoul, et al.
Publicado: (2011)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Is Myocardial Fibrosis Impairing Right Heart Function?
por: Bogaard, Harm Jan, et al.
Publicado: (2019)

Targeting Human Herpesviruses: An Effective Strategy for Treating Idiopathic Pulmonary Fibrosis?
por: Maher, Toby M.
Publicado: (2021)

Flu and pulmonary fibrosis
por: Sharma, Bharat Bhushan, et al.
Publicado: (2013)

B Cells in Idiopathic Pulmonary Fibrosis: Targeting Immune Cells with Antifibrotic Agents
por: Roman, Jesse, et al.
Publicado: (2021)

Kindlin for the Fire: Targeting Proline Synthesis to Extinguish Matrix Production in Pulmonary Fibrosis
por: Guzy, Robert, et al.
Publicado: (2021)

Right Ventricular Longitudinal Strain: A Target Indicator in the Treatment of Pulmonary Arterial Hypertension
por: Cho, Kyoung Im
Publicado: (2015)

Genomic Classifiers in Diagnosing Interstitial Lung Disease: Finding the Right Place at the Right Time
por: Goobie, Gillian C., et al.
Publicado: (2022)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
por: Strykowski, Rachel, et al.
Publicado: (2021)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Demystifying the Enigmatic Fibroblast in Pulmonary Fibrosis
por: Zhou, Yong, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

Pulmonary Fibrosis in the Time of COVID-19
por: Buendia-Roldan, Ivette, et al.
Publicado: (2022)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

Two Birds with One Stone: Helping the Pulmonary Arteries and the Right Ventricle by Targeting BMPR2 Signaling
por: Lee, Michael H., et al.
Publicado: (2021)

Lung Fibrosis Finds an Unsung Hero in Neuropeptide Y
por: Madala, Satish K., et al.
Publicado: (2022)

Unilateral Pulmonary Fibrosis Due to Absence of Right Pulmonary Artery
por: Sumdani, Hasan, et al.
Publicado: (2019)

Cell Based Therapies: At Crossroads to find the right Cell source
Publicado: (2012)

Using Families to Study Pulmonary Fibrosis Genetics
por: Allen, Richard J.
Publicado: (2023)

Proteostasis Takes Center Stage in Pulmonary Fibrosis
por: Budinger, G. R. Scott
Publicado: (2019)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Remember Me? The Bone Marrow in Pulmonary Fibrosis
por: Rangarajan, Sunad, et al.
Publicado: (2019)

A Focus on “Eye on” Channels in Pulmonary Fibrosis
por: Scheraga, Rachel G., et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

CRTH2 in Pulmonary Fibrosis: Friend or Foe?
por: He, Chao, et al.
Publicado: (2022)

Viral Infection, Pulmonary Fibrosis, and Long COVID
por: Hatabu, Hiroto, et al.
Publicado: (2022)

How to Determine Right Ventricular Dysfunction in Pulmonary Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2021)

Is it right to look for anti-cancer drugs amongst compounds having antioxidant effect?
por: Abdollahi, Mohammad, et al.
Publicado: (2012)

Goldilocks and the Three Trials: Clinical Trials Targeting the α(v)β(6) Integrin in Idiopathic Pulmonary Fibrosis
por: Sime, Patricia, et al.
Publicado: (2022)

Nutrition in Cystic Fibrosis: as important as the management of pulmonary disease
por: Adde, Fabíola Villac
Publicado: (2015)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis
por: O’Dwyer, David N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7en2o6p8sd71rkjt6dre6pqqga